ArticleWorld journal of urology2025
Transurethral resection of the prostate in the extreme elderly (≥ 85 years): treatment success, morbidity and survival.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Efficacy of transurethral thulium laser vapoenucleation of the prostate combined with 12-o'clock urethral mucosal preservation for small-volume benign prostatic hyperplasia: a retrospective study.World journal of urology · 2026Article
- Letter to the editor: "Association of the G8 score with urinary continence recovery after robot-assisted radical prostatectomy".World journal of urology · 2026Article
- Modified water vapor thermal therapy for large-volume benign prostatic hyperplasia.BMC urology · 2026Article
- Systemic endocrine benefits of benign prostatic obstruction surgery.World journal of urology · 2025Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThere are few studies evaluating the outcomes associated with transurethral resection of the prostate (TURP) in extremely elderly men. Our objective was to assess the safety and efficacy of this procedure in this special population.
methodsAs part of an ethically approved study, retrospective review was carried out of all patients ≥ 85 years who underwent TURP between 2014 and 2023 at a tertiary centre. Data was collected on demographics including frailty status, operative data and complications. Treatment success was defined as catheter free status.
resultsOver the study period, 194 patients (median age 87 years, IQR 86-89) underwent TURP, with a median follow-up of 6 years (IQR 3.5-8). The majority (68%) were ASA 3. 28% received home nursing assistance or were nursing home residents at the time of surgery. Median CCI score was 2 (IQR 1-3). 66% used anticoagulant medication. 97% received spinal anaesthesia and median operative time was 63 min (IQR 39-88). The intra-operative complication rate was 2.6%. The 30-day complication rate was 30% (Clavien-Dindo (CD) 1-2: 24%, ≥ CD 3: 5.7%). Among those with a catheter preoperatively (62%, n = 120), 84% had achieved spontaneous voiding (n = 101) at three month follow up. Overall, 93% were still alive at 1 year post surgery. The cumulative reoperation rate during study follow up was 7.2% at 1 year, 10.9% at 3 years, and 11.5% at 5 years.
conclusionTreatment success for TURP in extremely elderly men (≥ 85 years) is high, but the associated morbidity burden warrants the need for an individualised approach when considering men in this special population who are potential candidates for surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.